Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada (vol 25, pg 32, 2018)

被引：0
|
作者：
Chua, A.
Perrin, A.
Ricci, J. F.
Neary, M. P.
Thabane, M.
机构：
来源：
CURRENT ONCOLOGY | 2018年 / 25卷 / 04期
关键词：
D O I：
10.3747/co.25.4233
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E354 / E355
页数：2
相关论文
共 50 条
  • [41] Cost-Effectiveness of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
    Kuhlmann, A.
    Schmidt, T.
    Treskova, M.
    Golpon, H.
    Welte, T.
    Von der Schulenburg, J. -Graf
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2302 - S2303
  • [42] Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia (vol 24, pg 103, 2020)
    Ganz, M. L.
    Chavan, A.
    Dhanda, R.
    Serbin, M.
    Yonan, C.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1108 - 1108
  • [43] Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression (vol 38, pg 954, 2004)
    Hemels, MEH
    Kasper, S
    Walter, E
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1545 - 1545
  • [44] Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran (vol 21, pg 282, 2018)
    Amiri, A.
    Goudarzi, R.
    Amiresmaili, M.
    Iranmanesh, F.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (03) : 312 - 312
  • [45] Cost-Effectiveness of Intensive Short-Term Dynamic Psychotherapy Trial Therapy (vol 87, pg 255, 2018)
    Abbass, A.
    Kisley, S.
    Town, J.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2020, 89 (05) : 336 - 336
  • [46] Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States (vol 24, pg 29, 2018)
    Carlson, J. J.
    Guzauskas, G. F.
    Chapman, R. H.
    Synnott, P. G.
    Liu, S.
    Russo, E. T.
    Pearson, S. D.
    Brouwer, E. D.
    Ollendorf, D. A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 714 - 716
  • [47] Cost-Effectiveness of Product Reformulation in Response to the Health Star Rating Food Labelling (vol 10, pg 614, 2018)
    Herrera, Ana Maria Mantilla
    Crino, Michelle
    Erskine, Holly E.
    Sacks, Gary
    Ananthapavan, Jaithri
    Mhurchu, Cliona Ni
    Lee, Yong Yi
    NUTRIENTS, 2018, 10 (08):
  • [48] Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia (vol 36, pg 1463, 2018)
    Bounthavong, Mark
    Butler, Javed
    Dolan, Chantal M.
    Dunn, Jeffrey D.
    Fisher, Kathryn A.
    Oestreicher, Nina
    Pitt, Bertram
    Hauptman, Paul J.
    Veenstra, David L.
    PHARMACOECONOMICS, 2019, 37 (08) : 1071 - 1071
  • [49] Cost-Effectiveness of Gene-Expression Profiling For Tumor-Site Origin (vol 16, pg 46, 2013)
    Hornberger, John
    Degtiar, Irina
    Gutierrez, Hialy
    Shewade, Ashwini
    Henner, W. David
    Becker, Shawn
    Varadhachary, Gauri
    Raab, Stephen
    VALUE IN HEALTH, 2013, 16 (02) : 452 - 452
  • [50] Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer (vol 147, pg 433, 2014)
    Diaby, Vakaramoko
    Adunlin, Georges
    Zeichner, Simon B.
    Avancha, Kiran
    Lopes, Gilberto
    Gluck, Stefan
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 443 - 443
12345